CYCCP Quote, Trading Chart, Cyclacel Pharmaceuticals Inc. 6% Convertible Preferred Stock
home / stock / cyccp / cyccp quote
$9.38 Last:
-0.32% Change Percent:
$9.38 Open:
$9.38 Previous Close:
$9.38 High:
$9.38 Low:
162 Volume:
06/07/2021 04:42:40 am Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
CYCCP Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-06-07 | 9.38 | 9.38 | 9.38 | 9.38 | 162 |
| 2021-06-04 | 9.4 | 9.41 | 9.41 | 9.4 | 355 |
| 2021-06-03 | 9.3801 | 9.3801 | 9.3801 | 9.3801 | 100 |
| 2021-05-31 | 9.38 | 9.38 | 9.38 | 9.38 | 201 |
| 2021-05-28 | 9.38 | 9.38 | 9.38 | 9.38 | 201 |
| 2021-05-27 | 10.01 | 10.45 | 10.45 | 10.01 | 509 |
| 2021-05-21 | 9.25 | 10.48 | 10.48 | 9.25 | 1,120 |
| 2021-05-20 | 9.25 | 9.25 | 9.25 | 9.25 | 258 |
| 2021-05-19 | 8.55 | 9.37 | 9.37 | 8.5 | 436 |
| 2021-05-18 | 8.28 | 8.4 | 8.7074 | 8.28 | 1,830 |
| 2021-05-10 | 8 | 8.0307 | 8.05 | 8 | 1,032 |
| 2021-05-07 | 7.6 | 7.6 | 7.6 | 7.6 | 180 |
| 2021-05-04 | 7.65 | 7.65 | 7.65 | 7.65 | 862 |
| 2021-05-03 | 7.66 | 7.65 | 7.66 | 7.65 | 251 |
| 2021-04-29 | 7.73 | 7.73 | 7.73 | 7.73 | 260 |
| 2021-04-28 | 7.73 | 7.73 | 7.73 | 7.73 | 718 |
| 2021-04-27 | 7.8499 | 7.8499 | 7.8499 | 7.8499 | 200 |
| 2021-04-26 | 7.94 | 7.94 | 7.94 | 7.94 | 200 |
| 2021-04-23 | 8.04 | 7.5862 | 8.05 | 7.5862 | 1,600 |
| 2021-04-15 | 9.3 | 8.395 | 9.3 | 8.38 | 625 |
Cyclacel Pharmaceuticals Inc. 6% Convertible Preferred Stock Company Name:
CYCCP Stock Symbol:
NASDAQ Market:
News, Short Squeeze, Breakout and More Instantly...
-
- Announces IND Authorization by FDA for Fadraciclib, a CDK2/9 Inhibitor, in Solid Tumors - - Recent Publication Reported that Overactive KRAS Mutants are Impeded by CDK9 Inhibition - - Following Recent Financing, Cash Runway Extended to Early 2023 - - Conf...
-
BERKELEY HEIGHTS, N.J., May 05, 2021 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, will announce first quarter financial results an...
-
BERKELEY HEIGHTS, N.J., March 16, 2021 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today announced the closing of its previously ...